Itrabest (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By preventing ergosterol formation, the drug disrupts the integrity of the fungal cell membrane, leading to inhibited growth and eventual cell death of susceptible fungi.

The dosage of Itrabest is determined by the prescribing clinician based on the specific infection, its severity, the patient’s weight, renal and hepatic function, and other clinical factors. Only a qualified healthcare professional should set the appropriate regimen.

Safety data for itraconazole in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Itrabest, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with fluconazole, another azole class drug, itraconazole has a broader spectrum against dimorphic fungi such as Histoplasma and Blastomyces and offers stronger activity against dermatophytes. However, itraconazole has more potential for drug‑drug interactions and requires monitoring of liver function, whereas fluconazole is generally better tolerated but less effective for certain deep‑seated infections.

Itrabest should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, direct sunlight and excessive heat. Do not refrigerate or freeze unless specifically instructed by the manufacturer.

Itrabest is taken orally, usually with a full glass of water. Depending on the formulation and prescribing information, it may be recommended to take the dose with food to improve absorption, or on an empty stomach to avoid interaction with antacids. Patients should follow the specific instructions provided by their prescriber.

The most serious adverse events include hepatotoxicity (elevated liver enzymes or liver failure), congestive heart failure exacerbation, severe allergic reactions such as anaphylaxis, and cardiac arrhythmias related to QT‑interval prolongation. Prompt medical attention is required if any signs of liver injury, breathlessness, swelling, or severe rash develop.

Itrabest is contraindicated in individuals with known hypersensitivity to itraconazole or any azole antifungal, patients with existing severe heart failure, and those with significant hepatic impairment. It should also be avoided in patients taking medications that have a major interaction risk, unless the prescriber determines that benefits outweigh the risks.